Doramapimod
Cat.No:ID1230 Solarbio
CAS:285983-48-4
Molecular Formula:C31H37N5O3
Molecular Weight:527.66
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥99%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > MAPK > DoramapimodCAS:285983-48-4
Molecular Formula:C31H37N5O3
Molecular Weight:527.66
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥99%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 285983-48-4 |
| Name | Doramapimod |
| Molecular Formula | C31H37N5O3 |
| Molecular Weight | 527.66 |
| Solubility | Soluble in DMSO |
| Purity | ≥99% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 1308068-626-2 |
| MDL | MFCD09752957 |
| SMILES | O=C(NC1=CC(C(C)(C)C)=NN1C2=CC=C(C)C=C2)NC3=C4C=CC=CC4=C(OCCN5CCOCC5)C=C3 |
| Target Point | p38 MAPK |
| Passage | MAPK |
| Background | Doramapimod is a potent p38α inhibitor |
| Biological Activity | Doramapimod 是一种高效的 p38α 抑制剂,IC50 为 4 nM,也抑制 B-Raf 和 Abl,IC50 分别为 83 nM 和 14.6 μM[1-5]。 |
| IC50 | IC50:83.4nM B-Raf);4nM(p38α);14600nM(Abl0)[1-5] |
| Data Literature Source | [1]. Dietrich J,et al. The design,synthesis,and evaluation of 8 hybrid DFG-out allosteric kinase inhibitors: a structural analysis of the binding interactions of Gleevec,Nexavar,and BIRB-796. Bioorg Med Chem. 2010 Aug 1;18(15):5738-48 [2]. Pargellis C,et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat Struct Biol,2002,9(4),268-272. [3]. Kuma Y,et al. BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J Biol Chem,2005,280(20),19472-19479. [4]. He D,et al. BIRB796,the inhibitor of p38 mitogen-activated protein kinase,enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cells. PLoS One. 2013;8(1):e54181. [5]. Park JK,et al. p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension. 2007 Mar;49(3):481-9 |
| Unit | Bottle |
| Specification | 10mg 50mg 100mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download